Literature DB >> 26406367

No driver behind the wheel? Targeting transcription in cancer.

Hector L Franco1, W Lee Kraus2.   

Abstract

Exploiting the dependence of cancer cells on transcription can be used as an effective strategy for targeting aggressive and therapeutically recalcitrant tumors. Wang et al. show that inhibiting transcription using THZ1, a small-molecule inhibitor of cyclin-dependent kinase CDK7, induces apoptotic cell death in triple-negative breast cancers.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26406367     DOI: 10.1016/j.cell.2015.09.013

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  14 in total

1.  THZ1 reveals CDK7-dependent transcriptional addictions in pancreatic cancer.

Authors:  Ping Lu; Jing Geng; Lei Zhang; Yu Wang; Ningning Niu; Yuan Fang; Fang Liu; Juanjuan Shi; Zhi-Gang Zhang; Yong-Wei Sun; Li-Wei Wang; Yujie Tang; Jing Xue
Journal:  Oncogene       Date:  2019-01-28       Impact factor: 9.867

2.  Chromatin Kinases Act on Transcription Factors and Histone Tails in Regulation of Inducible Transcription.

Authors:  Steven Z Josefowicz; Miho Shimada; Anja Armache; Charles H Li; Rand M Miller; Shu Lin; Aerin Yang; Brian D Dill; Henrik Molina; Hee-Sung Park; Benjamin A Garcia; Jack Taunton; Robert G Roeder; C David Allis
Journal:  Mol Cell       Date:  2016-10-20       Impact factor: 17.970

3.  CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification.

Authors:  Jae Young Hur; Hyeong Ryul Kim; Jung Yeon Lee; Sojung Park; Ji An Hwang; Woo Sung Kim; Shinkyo Yoon; Chang-Min Choi; Jin Kyung Rho; Jae Cheol Lee
Journal:  Cell Oncol (Dordr)       Date:  2019-03-05       Impact factor: 6.730

Review 4.  PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes.

Authors:  Rebecca Gupte; Ziying Liu; W Lee Kraus
Journal:  Genes Dev       Date:  2017-01-15       Impact factor: 11.361

5.  Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis.

Authors:  Hector L Franco; Anusha Nagari; Venkat S Malladi; Wenqian Li; Yuanxin Xi; Dana Richardson; Kendra L Allton; Kaori Tanaka; Jing Li; Shino Murakami; Khandan Keyomarsi; Mark T Bedford; Xiaobing Shi; Wei Li; Michelle C Barton; Sharon Y R Dent; W Lee Kraus
Journal:  Genome Res       Date:  2017-12-22       Impact factor: 9.043

6.  Covalent CDK7 Inhibitor THZ1 Inhibits Myogenic Differentiation.

Authors:  Xinqi Ma; Xielan Kuang; Qing Xia; Zixin Huang; Yuting Fan; Jie Ning; Jiajie Wen; Han Zhang; Jianhua Yan; Qingjiong Zhang; Huangxuan Shen; Chongde Long
Journal:  J Cancer       Date:  2018-08-06       Impact factor: 4.207

7.  Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 Overexpression.

Authors:  Cody T Mowery; Jaime M Reyes; Lucia Cabal-Hierro; Kelly J Higby; Kristen L Karlin; Jarey H Wang; Robert J Kimmerling; Paloma Cejas; Klothilda Lim; Hubo Li; Takashi Furusawa; Henry W Long; David Pellman; Bjoern Chapuy; Michael Bustin; Scott R Manalis; Thomas F Westbrook; Charles Y Lin; Andrew A Lane
Journal:  Cell Rep       Date:  2018-11-13       Impact factor: 9.423

Review 8.  Therapeutic targeting of transcriptional cyclin-dependent kinases.

Authors:  Matthew D Galbraith; Heather Bender; Joaquín M Espinosa
Journal:  Transcription       Date:  2018-11-09

9.  TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets.

Authors:  Bieke Decaesteker; Geertrui Denecker; Christophe Van Neste; Emmy M Dolman; Wouter Van Loocke; Moritz Gartlgruber; Carolina Nunes; Fanny De Vloed; Pauline Depuydt; Karen Verboom; Dries Rombaut; Siebe Loontiens; Jolien De Wyn; Waleed M Kholosy; Bianca Koopmans; Anke H W Essing; Carl Herrmann; Daniel Dreidax; Kaat Durinck; Dieter Deforce; Filip Van Nieuwerburgh; Anton Henssen; Rogier Versteeg; Valentina Boeva; Gudrun Schleiermacher; Johan van Nes; Pieter Mestdagh; Suzanne Vanhauwaert; Johannes H Schulte; Frank Westermann; Jan J Molenaar; Katleen De Preter; Frank Speleman
Journal:  Nat Commun       Date:  2018-11-19       Impact factor: 14.919

10.  Transcriptional control by enhancers and enhancer RNAs.

Authors:  Michael W Lewis; Shen Li; Hector L Franco
Journal:  Transcription       Date:  2019-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.